Table 1.
Demographic and treatment characteristics of cervical cancer patients by HIV status.
| HIV-positive |
HIV-negative |
Total |
||||
|---|---|---|---|---|---|---|
| n | Percentage (%) | N | Percentage (%) | n | Percentage (%) | |
| Total | 123 | 100.00 | 45 | 100.00 | 168 | 100.00 |
| Age (years) | ||||||
| Median | 47 | 66 | 49 | |||
| IQR | 42–53 | 57–72 | 43–61 | |||
| 20–39 | 21 | 17.07 | 4 | 8.89 | 25 | 14.88 |
| 40–59 | 78 | 63.41 | 9 | 20.00 | 87 | 51.79 |
| ≥60 | 15 | 12.20 | 31 | 68.89 | 46 | 27.38 |
| No records | 9 | 7.32 | 1 | 2.22 | 10 | 5.95 |
| FIGO cervical stage | ||||||
| Stage I | 13 | 10.57 | 5 | 11.11 | 18 | 10.71 |
| Stage II | 30 | 24.39 | 12 | 26.67 | 42 | 25.00 |
| Stage III | 34 | 27.64 | 19 | 42.22 | 53 | 31.55 |
| Stage IV | 22 | 17.89 | 3 | 6.67 | 25 | 14.88 |
| Unknown/no record | 24 | 13.16 | 6 | 13.33 | 30 | 17.86 |
| CD4 count (cells/μL) | ||||||
| Median | 479.5 | n/a | ||||
| IQR | 324.2–649.2 | n/a | ||||
| HIV viral load | ||||||
| Detected | 17 | 13.82 | n/a | n/a | ||
| Not detected | 91 | 73.98 | n/a | n/a | ||